scholarly journals Quality of Patient Information by Urologists Is Associated with Mental Distress in Bladder Cancer Patients

2020 ◽  
Vol 43 (5) ◽  
pp. 228-236
Author(s):  
Jens Mani ◽  
Marie-Therese Neuberth ◽  
Jens Fettel ◽  
Bianca Senf ◽  
Wael Khoder ◽  
...  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Kristin Zimmermann ◽  
Hadi Mostafaei ◽  
Axel Heidenreich ◽  
Hans U. Schmelz ◽  
Shahrokh F. Shariat ◽  
...  

2018 ◽  
Vol 7 (S1) ◽  
pp. S111-S113
Author(s):  
Massimiliano Creta ◽  
Nicola Longo ◽  
Ciro Imbimbo ◽  
Vittorio Imperatore ◽  
Vincenzo Mirone ◽  
...  

2020 ◽  
Vol 38 (6_suppl) ◽  
pp. 463-463
Author(s):  
Pauline Filippou ◽  
Sean McCabe ◽  
Hannah McCloskey ◽  
Kathryn Gessner ◽  
Judy Hamad ◽  
...  

463 Background: Quality of life among cancer survivors has been shown to vary by age. Our objective was to evaluate differences in general and bladder cancer-specific quality of life based on age among a large cross-sectional bladder cancer cohort. Methods: We performed a cross-sectional survey of bladder cancer patients using the Bladder Cancer Advocacy Network Patient Survey Network and Inspire platforms to determine general and bladder cancer-specific quality of life (QOL) using the EORTC QLQ-C30 and Bladder Cancer Index. Patients were also queried regarding demographic, socioeconomic and clinical characteristics. We present descriptive statistics and a multiple linear regression model to identify factors independently associated with QOL domain score. Results: 972 respondents self-identified as patients with bladder cancer, of whom 41% were female and 97 % were white. The mean age was 67.6 years (range 29 to 93 years). Respondents were highly educated (67% completed college). 63% of patients identified as having non-invasive (NMIBC) cancer (n=578), 30% had MIBC (n=270), and 7% had metastatic bladder cancer (n=63). On multivariable analysis, older age was significantly associated with better generic QOL and urinary function ( Table), but not sexual function (p=0.19) or bowel function (p=0.73), controlling for sex, race, stage, comorbidity and years since diagnosis. Conclusions: Higher general and domain-specific QOL scores are more common among older bladder cancer patients. Differential impact by age may be important for the development of tailored interventions to improve QOL for bladder cancer patients. [Table: see text]


2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Marianne Casilla-Lennon ◽  
Seul Ki Cho ◽  
Allison Deal ◽  
Gopal Narang ◽  
Jeannette Bensen ◽  
...  

2021 ◽  
Vol 10 (23) ◽  
pp. 5472
Author(s):  
Yuh-Shyan Tsai ◽  
Tzu-Yi Wu ◽  
Yeong-Chin Jou ◽  
Tzong-Shin Tzai ◽  
Jung-Der Wang

We measured and determined the factors associated with long-term generic quality-of-life (QOL) changes in human bladder cancer patients. We utilized the World Health Organization QOL-Brief questionnaire to assess consecutive patients’ QOL at outpatient clinics of our hospital. A mixed-effects model was constructed to investigate the determinants of QOL changes according to each domain and individual item after controlling for demographic and clinical factors, as well as the effect of radical cystectomy. We also applied a kernel smoothing method to describe the long-term dynamic changes after the first definite treatment. In total, 1185 repeated measurements were collected from 343 bladder cancer patients. The mixed-effects models demonstrated that marital status, monthly income, and comorbidity with heart disease and diabetes were significant determinants among all the study participants. Regardless of the urinary diversion type, radical cystectomy contributed to lower scores for all four domains, mainly from 4–5 years after cystectomy, which declined significantly in patients who were older than 60 years. As for non-muscle-invasive bladder cancer (NMIBC) patients with preserved bladders, tumor recurrence was a major predictor for lower scores for sexual activity in the social domain. In summary, generic QOL can be independently influenced by many factors, not only cystectomy and tumor recurrence, which should be discussed with patients before treatment.


Sign in / Sign up

Export Citation Format

Share Document